六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001558370-22-014879 Act: 34 Size: 241 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-22-014838 Act: 34 Size: 209 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-22-014678 Act: 34 Size: 657 KB 网页链接
$Aytu BioPharma(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-22-014659 Act: 34 Size: 23 KB 网页链接
$Aytu BioPharma(AYTU)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-22-014652 Act: 34 Size: 17 MB 网页链接
$Aytu BioPharma(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-22-014511 Act: 34 Size: 28 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-22-014484 Act: 34 Size: 266 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-22-014394 Act: 34 Size: 279 KB 网页链接
$Aytu BioPharma(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-22-013952 Act: 34 Size: 786 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-22-013712 Act: 34 Size: 274 KB 网页链接